Breathe America, Inc.: Series B $22M

Posted in I - Series B, Q - 3Q11, R - SOUTH EAST, X - Allergy, X - Asthma, X - Sinus, XX - TN

Breathe America (Nashville, TN) a commercial-stage clinical company focused on the treatment of chronic airway diseases, allergy, sinus and asthma, closed a $22M Series B financing. Participants include Essex Woodlands.
Thanx for your patience as we catch-up.

ABT Molecular Imaging, Inc.: Series A $9M

Posted in I - Series A, Q - 4Q09, R - SOUTH EAST, X - Biomarker, X - Device (Imaging), XX - TN

ABT Molecular Imaging (Knoxville, TN) medical imaging company developing a production platform to generate unit doses of molecular imaging drugs for positron emission tomography (PET) scanning at the point of use, closed a $9M Series A financing. Participants include Intersouth Partners.
Note: 2009 Year-in-Review Trend Analysis Coming 15 Feb.

Active Implants Corp.: Series C $10M

Posted in I - Series C, Q - 2Q09, R - SOUTH EAST, X - Device (Orthopedic), XX - TN

Active Implants (Memphis, TN) a development-stage company focused on medical grade polycarbonate urethane for hip and knee orthopedic implants, closed a $10M Series C financing. Participants in the round were not identified.

ProstimRx Corp.: Series A $5M

Posted in I - Series A, Q - 4Q08, R - SOUTH EAST, X - Device (Prostate), XX - TN

ProstimRx (Hendersonville, TN) an early-stage developer of medical devices for the treatment of the treatment of prostatitis, benign prostate hypertrophy, erectile dysfunction and other prostate-related disorders closed a $5M Series A financing. Participants include M.D. Venture Partners.

to top of page...